MEDIFAST
Yahoo Finance • 25 days ago
1 Unpopular Stock That Should Get More Attention and 2 We Turn Down
1 Unpopular Stock That Should Get More Attention and 2 We Turn Down Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate... Full story
Yahoo Finance • 26 days ago
MNST's International Sales Surge 35%: Is Global Expansion Paying Off?
Monster Beverage Corporation's MNST international business is emerging as a major growth engine, supported by healthy energy-drink demand, product innovation and deeper execution with Coca-Cola bottling partners. The company continues to e... Full story
Yahoo Finance • 27 days ago
Can Colgate Revive North America Growth in the Second Half?
Colgate-Palmolive Company CL is stepping up efforts to improve its North America business after a challenging second quarter of 2026. Management expressed dissatisfaction with the region's performance, which was hurt by category softness,... Full story
Yahoo Finance • 28 days ago
Embedded Systems Market Outlook 2026-2035 - Featuring Profiles of Intel, NXP Semiconductors, and Renesas Electronics
Company Logo Embedded Systems Market Gains Momentum as Edge AI, IoT and Industry 4.0 Drive Smart, Energy-Efficient Solutions Across Key Industries Dublin, Sept. 15, 2026 (GLOBE NEWSWIRE) -- "Embedded Systems Market Opportunity, Growth Dr... Full story
Yahoo Finance • last month
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report?
A month has gone by since the last earnings report for Medifast (MED). Shares have lost about 7.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Med... Full story
Yahoo Finance • last month
Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Sept. 2, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE... Full story
Yahoo Finance • 2 months ago
Can Medifast Capitalize on Rising GLP-1 Use With Metabolic Health?
Medifast, Inc. MED is advancing its strategic transition toward metabolic health, with management expecting positive trends to continue through the remainder of the year. The launch of its new consumer brand, Trilivy, marks the first step... Full story
Yahoo Finance • 2 months ago
All You Need to Know About Medifast (MED) Rating Upgrade to Buy
Medifast (MED) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. The... Full story
Yahoo Finance • 2 months ago
3 Reasons to Sell MED and 1 Stock to Buy Instead
3 Reasons to Sell MED and 1 Stock to Buy Instead Medifast trades at $11.62 per share and has stayed right on track with the overall market, gaining 9.6% over the last six months. At the same time, the S&P 500 has returned 12.7%. Is there... Full story
Yahoo Finance • 2 months ago
Bullish Two Hundred Day Moving Average Cross - MED
In trading on Tuesday, shares of Medifast Inc (Symbol: MED) crossed above their 200 day moving average of $11.20, changing hands as high as $13.44 per share. Medifast Inc shares are currently trading up about 37.2% on the day. The chart... Full story
Yahoo Finance • 2 months ago
Medifast targets return to profitability in Q4 2026 as Trilivy rollout continues
Earnings Call Insights: Medifast (MED) Q2 2026 MANAGEMENT VIEW * CEO & President Nicholas Johnson said Q2 continued “positive indicators,” highlighting that “revenue has stabilized sequentially over the recent quarters, aided by higher... Full story
Yahoo Finance • 3 months ago
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
BALTIMORE, July 20, 2026--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, will announce financial results for the quarter ended J... Full story
Yahoo Finance • 3 months ago
3 Unpopular Stocks That Concern Us
3 Unpopular Stocks That Concern Us Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps deliv... Full story
Yahoo Finance • 5 months ago
Stocks to watch on Tuesday after-hours: ZS, MED, FLY
[Stock market activity shows price changes and trading movements in real time] FabrikaCr Wall Street’s major market averages finished mostly higher on Tuesday as investors assessed the possibility of a resolution in the U.S.-Iran conflict... Full story
Yahoo Finance • 5 months ago
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do
A randomized controlled trial published in Obesity Science & Practice found that clients on the OPTAVIA Optimal Weight 5 & 1 Plan® who worked with a coach lost significantly more weight and fat than those who attempted the program without... Full story
Yahoo Finance • 5 months ago
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes
70% of users discontinued use of lifestyle behavior and health apps within the first 100 days (Kidman PG, et al., 2024)Early weight loss at week four is a strong predictor of clinically relevant outcomes, with research identifying addition... Full story
Yahoo Finance • 5 months ago
Peer-Reviewed Research Is Redefining Weight Loss Program Standards
The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the categoryRandomized controlled trials control for the lifestyle variables and selection... Full story
Yahoo Finance • 5 months ago
Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation
Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al., 2019)Structured plans, habit building, and dedicated coach support work together to produce body com... Full story
Yahoo Finance • 5 months ago
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026
Earnings Call Insights: Medifast (MED) Q1 2026 MANAGEMENT VIEW * "We are seeing further evidence that our business is at the beginning of a period of stabilization and that we are making meaningful progress in delivering tangible tract... Full story
Yahoo Finance • 5 months ago
Medifast Q1 2026 Earnings Preview
* Medifast (MED [https://seekingalpha.com/symbol/MED]) is scheduled to announce Q1 earnings results on Monday, May 4th, after market close. * The consensus EPS Estimate is -$0.52 [https://seekingalpha.com/symbol/MED/earnings/estimates]... Full story